Breathe Well Live Well
Condition: Asthma
Interventions: Drug: Treatment A: Fp MDPI; Drug: Treatment B: FS MDPI; Drug: Treatment C Flovent; Drug: Treatment D: Advair
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate); Drug: Advair (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate); Drug: Placebo
Sponsors: Mylan Inc.; Mylan Pharma UK Ltd.
Not yet recruiting – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Seretide Diskus and charcoal; Drug: Seretide Diskus; Drug: SF Easyhaler and charcoal; Drug: SF Easyhaler
Sponsors: Orion Corporation, Orion Pharma; Orion Corporation, Orion Pharma
Recruiting – verified May 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Studies Ordered for Side Effects of Symbicort, Advair Diskus, Dulera, Foradil
AboutLawsuits.com Federal drug regulators have ordered that new studies be done to examine potential safety problems with a number of asthma drugs, including Advair, Symbicort, Dulera and Foradil. The FDA announced it was requiring the new clinical safety trials on … Already Available Asthma Medications FDA Orders Trials |
View full post on asthma – Google News